Chargement en cours...
GLI1: A Therapeutic Target for Cancer
GLI1 is a transcriptional effector at the terminal end of the Hedgehog signaling (Hh) pathway and is tightly regulated during embryonic development and tissue patterning/differentiation. GLI1 has low-level expression in differentiated tissues, however, in certain cancers, aberrant activation of GLI1...
Enregistré dans:
| Publié dans: | Front Oncol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8186314/ https://ncbi.nlm.nih.gov/pubmed/34113570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.673154 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|